tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Germany Market
Advertisement

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Ratios

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Ratios

DE:6NQ's free cash flow for Q1 2025 was zł0.61. For the 2025 fiscal year, DE:6NQ's free cash flow was decreased by zł and operating cash flow was zł0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.03 1.47 2.26 2.38 0.90
Quick Ratio
0.79 0.97 1.74 1.83 0.53
Cash Ratio
<0.01 0.07 1.09 0.83 0.07
Solvency Ratio
0.08 0.07 0.21 0.26 0.21
Operating Cash Flow Ratio
0.42 -0.17 0.12 -0.19 0.01
Short-Term Operating Cash Flow Coverage
1.45 -0.68 0.43 -0.90 0.05
Net Current Asset Value
zł -132.39Mzł -107.69Mzł -2.17Mzł -1.44Mzł -26.53M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.26 0.09 0.06 0.15
Debt-to-Equity Ratio
0.63 0.62 0.14 0.09 0.36
Debt-to-Capital Ratio
0.39 0.38 0.13 0.08 0.26
Long-Term Debt-to-Capital Ratio
0.33 0.34 0.05 0.02 0.08
Financial Leverage Ratio
2.47 2.36 1.55 1.57 2.30
Debt Service Coverage Ratio
1.15 1.36 1.56 2.33 1.21
Interest Coverage Ratio
3.72 5.11 6.12 5.61 3.60
Debt to Market Cap
0.21 0.22 0.03 0.02 0.02
Interest Debt Per Share
1.12 1.02 0.26 0.12 0.24
Net Debt to EBITDA
3.62 4.56 -0.75 -0.60 1.06
Profitability Margins
Gross Profit Margin
63.16%60.00%55.44%55.08%51.21%
EBIT Margin
18.71%14.10%19.76%17.44%14.84%
EBITDA Margin
29.41%25.41%30.57%31.81%27.00%
Operating Profit Margin
16.85%14.75%19.53%17.48%14.76%
Pretax Profit Margin
13.93%11.21%16.57%14.32%10.74%
Net Profit Margin
10.39%8.12%12.07%10.32%11.05%
Continuous Operations Profit Margin
10.39%8.12%12.07%10.32%11.05%
Net Income Per EBT
74.59%72.43%72.86%72.10%102.90%
EBT Per EBIT
82.67%75.97%84.80%81.94%72.80%
Return on Assets (ROA)
2.48%1.79%3.73%3.64%5.17%
Return on Equity (ROE)
6.31%4.22%5.76%5.70%11.90%
Return on Capital Employed (ROCE)
4.72%3.68%7.10%7.22%9.67%
Return on Invested Capital (ROIC)
3.34%2.57%4.92%5.02%8.83%
Return on Tangible Assets
2.50%1.79%3.74%3.65%5.24%
Earnings Yield
2.18%1.59%1.55%1.52%0.80%
Efficiency Ratios
Receivables Turnover
2.05 2.89 0.00 3.54 3.84
Payables Turnover
1.23 8.14 8.08 10.42 9.25
Inventory Turnover
2.49 1.51 1.77 1.98 2.15
Fixed Asset Turnover
0.29 0.28 0.52 0.65 0.41
Asset Turnover
0.24 0.22 0.31 0.35 0.47
Working Capital Turnover Ratio
31.76 2.58 1.85 3.90 -9.98
Cash Conversion Cycle
27.50 322.61 160.91 252.08 225.12
Days of Sales Outstanding
178.16 126.36 0.00 103.00 95.04
Days of Inventory Outstanding
146.46 241.11 206.09 184.11 169.51
Days of Payables Outstanding
297.11 44.86 45.18 35.03 39.44
Operating Cycle
324.61 367.48 206.09 287.11 264.56
Cash Flow Ratios
Operating Cash Flow Per Share
0.26 -0.08 0.05 -0.05 <0.01
Free Cash Flow Per Share
-0.17 -1.68 -0.52 -0.34 -0.03
CapEx Per Share
0.43 1.60 0.56 0.29 0.03
Free Cash Flow to Operating Cash Flow
-0.63 22.07 -11.47 6.62 -4.90
Dividend Paid and CapEx Coverage Ratio
0.57 -0.05 0.08 -0.18 0.17
Capital Expenditure Coverage Ratio
0.61 -0.05 0.08 -0.18 0.17
Operating Cash Flow Coverage Ratio
0.24 -0.08 0.19 -0.51 0.03
Operating Cash Flow to Sales Ratio
0.26 -0.09 0.06 -0.08 <0.01
Free Cash Flow Yield
-3.44%-39.31%-8.63%-7.75%-0.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
45.87 63.05 64.41 65.96 125.67
Price-to-Sales (P/S) Ratio
4.77 5.12 7.77 6.81 13.89
Price-to-Book (P/B) Ratio
2.81 2.66 3.71 3.76 14.95
Price-to-Free Cash Flow (P/FCF) Ratio
-29.07 -2.54 -11.58 -12.91 -331.66
Price-to-Operating Cash Flow Ratio
18.44 -56.13 132.85 -85.42 1.63K
Price-to-Earnings Growth (PEG) Ratio
-5.05 -2.54 2.25 -36.18 1.60
Price-to-Fair Value
2.81 2.66 3.71 3.76 14.95
Enterprise Value Multiple
19.82 24.70 24.67 20.81 52.51
Enterprise Value
415.53M 367.88M 380.03M 272.46M 569.31M
EV to EBITDA
19.82 24.70 24.67 20.81 52.51
EV to Sales
5.83 6.28 7.54 6.62 14.18
EV to Free Cash Flow
-35.56 -3.12 -11.24 -12.55 -338.47
EV to Operating Cash Flow
22.56 -68.83 128.91 -83.04 1.66K
Tangible Book Value Per Share
1.68 1.60 1.61 1.17 0.58
Shareholders’ Equity Per Share
1.71 1.60 1.61 1.18 0.60
Tax and Other Ratios
Effective Tax Rate
0.25 0.28 0.27 0.28 -0.03
Revenue Per Share
1.01 0.83 0.77 0.65 0.65
Net Income Per Share
0.10 0.07 0.09 0.07 0.07
Tax Burden
0.75 0.72 0.73 0.72 1.03
Interest Burden
0.74 0.80 0.84 0.82 0.72
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.39 0.31 0.25 0.30 0.35
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.20 -0.81 0.35 -0.56 0.08
Currency in PLN
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis